Département biomédical et santé publique, Institut de Recherche en Sciences de la Santé (IRSS), Centre National de la Recherche Scientifique et Technologique (CNRST), Ouagadougou, Burkina Faso.
Université Paris-Dauphine, Université PSL, LEDa, CNRS, IRD, DIAL, Paris, France.
PLoS One. 2024 Aug 7;19(8):e0305850. doi: 10.1371/journal.pone.0305850. eCollection 2024.
Since March 2020, COVID-19 has evolved from a localized outbreak to a global pandemic. We assessed the seroprevalence of COVID-19 in three towns in the Centre Sud region of Burkina Faso.
A population-based cross-sectional survey was conducted in three middle-sized cities in Burkina Faso's Centre Sud region, from June to July 2021. Subjects aged 16 or over at the time of the survey were considered for this seroprevalence study. The Biosynex COVID-19 BSS rapid test was used to detect immunoglobulin G (IgG) and immunoglobulin M (IgM) against SARS-CoV-2. A standardized questionnaire was also administered to collect additional information.
A total of 2449 eligible participants (age ≥ 16 years) were identified. Serological tests for COVID-19 were performed in 2155 individuals, of which 2143 valid tests were retained and analyzed. Out of the entire sample, 246 positive tests were observed, corresponding to a prevalence of 11.48%. Prevalence was 9.35% (58 cases) in Kombissiri, 12.86% (80 cases) in Manga and 11.99% (108 cases) in Pô. By gender, 13.37% of women (164 cases) tested positive, and 8.95% of men (82 cases). Women accounted for 66.67% of all positive test subjects. The results from the multivariate analysis show a significantly higher seroprevalence in women (p = 0.007), people over 55 years old (p = 0.004), overweight people (p = 0.026) and those with drinking water sources at home (p = 0.013).
The results of this study show that the COVID-19 virus also circulates in the population of middle-sized cities in Burkina Faso, far more than officially reported by the information service of the government of Burkina Faso, given the lack of systematic testing in the general population in the country. The study also highlighted the greater vulnerability of women, older and overweight individuals to the epidemic. The preventive measures put in place to fight the pandemic must take these different factors into account.
自 2020 年 3 月以来,COVID-19 已从局部爆发演变为全球大流行。我们评估了布基纳法索中南部三个城镇的 COVID-19 血清流行率。
2021 年 6 月至 7 月,在布基纳法索中南部的三个中等城市进行了一项基于人群的横断面调查。在调查时年满 16 岁的受试者被纳入本血清流行率研究。使用 Biosynex COVID-19 BSS 快速检测试剂盒检测针对 SARS-CoV-2 的免疫球蛋白 G(IgG)和免疫球蛋白 M(IgM)。还使用标准化问卷收集其他信息。
共确定了 2449 名符合条件的参与者(年龄≥16 岁)。对 2155 名个体进行了 COVID-19 的血清学检测,其中保留并分析了 2143 份有效检测结果。在整个样本中,观察到 246 例阳性检测结果,患病率为 11.48%。在 Kombissiri 患病率为 9.35%(58 例),在 Manga 为 12.86%(80 例),在 Pô 为 11.99%(108 例)。按性别划分,13.37%的女性(164 例)检测结果为阳性,8.95%的男性(82 例)。所有阳性检测对象中,女性占 66.67%。多变量分析结果显示,女性(p=0.007)、55 岁以上人群(p=0.004)、超重人群(p=0.026)和家中饮用水源人群(p=0.013)的血清阳性率显著更高。
本研究结果表明,COVID-19 病毒也在布基纳法索中等城市的人群中传播,远远超过布基纳法索政府信息服务部门报告的官方数字,这是因为该国对普通人群没有进行系统检测。该研究还强调了女性、老年人和超重人群对该传染病的更大脆弱性。为抗击大流行而采取的预防措施必须考虑到这些不同的因素。